Cite
HARVARD Citation
Wang, R. et al. (2018). A novel enediyne‐integrated antibody–drug conjugate shows promising antitumor efficacy against CD30+ lymphomas. Molecular oncology. 12 (3), pp. 339-355. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, R. et al. (2018). A novel enediyne‐integrated antibody–drug conjugate shows promising antitumor efficacy against CD30+ lymphomas. Molecular oncology. 12 (3), pp. 339-355. [Online].